NF-κB signaling in cancer cells can be activated by factors such as IL-1β, TNFα and IL-8, IL-6 and MCP-1 secreted by cells in the microenvironment of the tumor, e.g. macrophages or adipocytes51–53. The gene discussed is CCL2; the disease is cancer.